RUNX3 inhibits survivin expression and induces cell apoptosis in gastric cancer
Authors:
- 1 March 2014
- journal article
- Published by Elsevier in European Journal of Cell Biology
- Vol. 93 (3) , 118-126
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (30800406, 81171536, 81371781, 81201935, 30972775, 30971151)
- National Basic Research Program of China
- Science Foundation of Shandong Province (BS2010YY040, ZR2009CZ001, ZR2009CM002)
- Medicine and Health Care in Shandong Province Science and Technology Development Plan (2013WS0205)
- Independent Innovative Foundation of Shandong University (2012TS126)
This publication has 37 references indexed in Scilit:
- Runx3 suppresses gastric cancer metastasis through inactivation of MMP9 by upregulation of TIMP‐1International Journal of Cancer, 2010
- RUNX3 is multifunctional in carcinogenesis of multiple solid tumorsOncogene, 2010
- Claudin-1 Has Tumor Suppressive Activity and Is a Direct Target of RUNX3 in Gastric Epithelial CellsGastroenterology, 2010
- Survivin, cancer networks and pathway-directed drug discoveryNature Reviews Cancer, 2008
- Are there useful biomarkers for gastric cancer?Digestive and Liver Disease, 2006
- RUNX3 Suppresses Gastric Epithelial Cell Growth by Inducing p21WAF1/Cip1 Expression in Cooperation with Transforming Growth Factor β-Activated SMADMolecular and Cellular Biology, 2005
- Down-regulation of Survivin in Nitric Oxide-induced Cell Growth Inhibition and Apoptosis of the Human Lung Carcinoma CellsJournal of Biological Chemistry, 2004
- Survivin, versatile modulation of cell division and apoptosis in cancerOncogene, 2003
- Induction of Apoptosis and Inhibition of Cell Proliferation bysurvivin Gene TargetingJournal of Biological Chemistry, 1998
- A novel anti-apoptosis gene, survivin, expressed in cancer and lymphomaNature Medicine, 1997